CFi.CN讯：佛慈制药（股票代码：002644）公布2021年年度报告摘要。

2021年末2020年末本年末比上年末增减2019年末
调整前调整后调整后调整前调整后
总资产2,352,093,709.482,267,132,508. 632,387,181,792. 19-1.47%2,314,892,098. 402,400,686,966. 23
归属于上市公司股东的净资产1,614,577,062.371,591,159,687. 971,582,090,699. 922.05%1,510,002,283. 5871,107,018.82
2021年2020年本年比上年增减2019年
调整前调整后调整后调整前调整后
营业收入817,640,826.02668,051,013.92668,051,013.9222.39%628,815,164.07628,815,164.07
归属于上市公司股东的净利润93,258,956.07111,981,040.00108,017,966.91-13.66%74,852,560.4971,107,018.82
归属于上市公司股东的扣除非经常性损益的净利润42,928,548.1718,731,623.7014,768,550.61190.68%-961,986.56-4,707,528.23
经营活动产生的现金流量净额11,854,642.4462,888,162.8062,888,162.80-81.15%47,822,985.3747,822,985.37
基本每股收益（元/股）0.18260.21930.2115-13.66%0.14660.1389
稀释每股收益（元/股）0.18260.21930.2115-13.66%0.14660.1389
加权平均净资产收益率5.72%7.15%6.98%-1.26%5.06%4.95%

推荐内容